BRIEF-Becton Dickinson to buy Bard for $24 billion
* Deal immediately accretive and expected to generate high single-digit accretion to adjusted EPS in fiscal year 2019 to Becton Dickinson
Oct 6 Kangmei Pharmaceutical Co Ltd :
* Says it to buy a Shenzhen-based pharmaceutical firm for 23 million yuan from two individuals
Source text in Chinese: goo.gl/OVd5aT
Further company Coverage: (Beijing Headline News)
NEW YORK, April 23 Becton Dickinson and Co will acquire C R Bard Inc in a $24 billion deal that will give shareholders of the target about 15 percent of the combined entity, the two medical technology companies said on Sunday.